Chilean Black Cherry

Chilean Black Cherry (Prunus serotina) is an anthocyanin-dense berry whose principal bioactives—cyanidin-3-glucoside (C3G), cyanidin-3-rutinoside (C3R), chlorogenic acid, and quercetin glycosides—neutralize reactive oxygen species via dual hydrogen atom transfer (HAT) and single-electron transfer (SET) mechanisms, inhibit NF-κB-mediated inflammation, and modulate endothelial nitric oxide synthase (eNOS) to support vascular function. While no PubMed-indexed clinical trials have been conducted specifically on Chilean-grown Prunus serotina fruit, its shared anthocyanin and phenolic acid profile with well-studied P. avium and P. cerasus species provides a robust mechanistic basis for its antioxidant, anti-inflammatory, and cardioprotective properties.

Origin & History

Chilean Black Cherry (Prunus serotina var. salicifolia) is native to the temperate rainforests, Andean valleys, and coastal regions of Chile and Argentina. This dark fruit is highly valued in functional nutrition for its potent antioxidant profile and benefits for cardiovascular, cognitive, and immune health.

Historical & Cultural Context

Revered in Indigenous Patagonian and Andean traditions as a sacred endurance fruit for circulatory strength and cognitive clarity. It was used in detox regimens and longevity rituals to sustain energy and immune defense.

Health Benefits

- Enhances cardiovascular function by improving vascular integrity and blood flow.
- Supports cognitive longevity by reducing oxidative stress and promoting neural protection.
- Regulates metabolism, contributing to balanced blood sugar and energy utilization.
- Boosts immune resilience through its rich content of vitamin C and anthocyanins.
- Improves circulation, supporting overall systemic health.
- Reduces inflammation via its potent polyphenol and flavonoid compounds.

How It Works

Chilean Black Cherry's primary anthocyanins—cyanidin-3-glucoside (C3G) and cyanidin-3-rutinoside (C3R)—scavenge superoxide anion (O₂⁻·), hydroxyl radicals (·OH), and peroxyl radicals through concurrent hydrogen atom transfer (HAT) from the B-ring catechol hydroxyl groups and single-electron transfer (SET) from the flavylium cation, achieving ORAC values comparable to those of tart cherry concentrates. These anthocyanins suppress the NF-κB signaling cascade by inhibiting IκB kinase (IKK) phosphorylation, thereby downregulating cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) gene expression—a dual anti-inflammatory mechanism that mirrors the action of non-steroidal anti-inflammatory drugs without gastrointestinal side effects. Chlorogenic acid and neochlorogenic acid potentiate these effects by inhibiting glucose-6-phosphate translocase in hepatocytes (reducing hepatic glucose output) and activating AMP-activated protein kinase (AMPK), which promotes mitochondrial biogenesis and fatty acid β-oxidation. Quercetin glycosides further enhance vascular protection by upregulating endothelial nitric oxide synthase (eNOS) via the PI3K/Akt pathway, increasing bioavailable nitric oxide and promoting vasodilation.

Scientific Research

As of 2025, no PubMed-indexed clinical trials have been conducted specifically on Chilean Black Cherry (Prunus serotina cultivated in Chile), representing a notable research gap. The current evidence base relies on well-documented studies of closely related Prunus species—sweet cherry (P. avium) and tart cherry (P. cerasus)—which share the same principal anthocyanins (cyanidin-3-glucoside, cyanidin-3-rutinoside) and phenolic acids (chlorogenic acid, neochlorogenic acid) found in Chilean Black Cherry. Research on these related species has demonstrated significant reductions in markers of oxidative stress (malondialdehyde, 8-isoprostane), inflammatory cytokines (IL-6, TNF-α, CRP), and uric acid levels in human participants. Future clinical investigations specifically targeting Chilean-grown Prunus serotina berries are needed to validate the translational applicability of these findings and to characterize any unique phytochemical advantages conferred by Chile's terroir and cultivar selection.

Clinical Summary

Current evidence is limited to in vitro studies and simulated digestion models, with no human clinical trials identified in the literature. Laboratory studies using Caco-2 cell models demonstrate anti-proliferative effects and cellular absorption of bioactive compounds. Antioxidant assays show measurable activity with ABTS values of 0.51 mg AAE/g and total antioxidant content of 2.79 mg AAE/g. Human clinical trials are needed to validate cardiovascular, cognitive, and metabolic benefits observed in preliminary research.

Nutritional Profile

- Phytochemicals: Rich in anthocyanins (cyanidin, delphinidin, malvidin), polyphenols (resveratrol, ellagic acid, catechins), flavonoids (quercetin, kaempferol, rutin), ellagitannins, and proanthocyanidins, providing powerful antioxidant and anti-inflammatory effects.
- Vitamins: Vitamin C and Vitamin E, supporting immune function and cellular protection.
- Minerals: Potassium, essential for electrolyte balance and cardiovascular health.
- Fiber: Soluble and insoluble fiber, promoting digestive health and satiety.

Preparation & Dosage

- Traditional preparation: Consumed fresh, fermented into tonics, or sun-dried for teas to support circulation, immunity, and longevity. Used in Mapuche and Andean medicine for detoxification, memory support, and cardiovascular resilience.
- Modern usage: Available as fresh/dried fruit or as extracts.
- Recommended dosage: 100–200g fresh/dried fruit or 500–1000 mg extract daily for heart, brain, and metabolic support.

Synergy & Pairings

Role: Polyphenol-dense base
Intention: Cardio & Circulation | Immune & Inflammation
Primary Pairings: - Turmeric (Curcuma longa)
- Camu Camu (Myrciaria dubia)
- Maca Root (Lepidium meyenii)
- Ginger (Zingiber officinale)

Safety & Interactions

Chilean Black Cherry is generally considered safe when consumed as a whole food or as a dietary supplement at standard doses; however, individuals taking anticoagulant or antiplatelet medications (e.g., warfarin, aspirin, clopidogrel) should exercise caution, as anthocyanins and quercetin have demonstrated mild platelet aggregation–inhibitory activity in vitro. Chlorogenic acid may inhibit CYP1A2 and CYP2C9 hepatic enzymes at high concentrations, potentially altering the metabolism of substrates such as caffeine, theophylline, and certain NSAIDs, though clinically significant interactions at dietary intake levels have not been established. Individuals with known stone-fruit allergies (Prunus genus; Pru av 1 and related PR-10 allergens) should avoid consumption due to potential cross-reactivity. Pregnant or breastfeeding women should consult a healthcare provider before using concentrated Chilean Black Cherry extracts, as high-dose anthocyanin supplementation has not been adequately studied in these populations.